John Evans
2019
In 2019, John Evans earned a total compensation of $2.2M as CEO at Beam Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $367,813 |
|---|---|
| Option Awards | $1,368,453 |
| Salary | $472,500 |
| Other | $1,034 |
| Total | $2,209,800 |
Evans received $1.4M in option awards, accounting for 62% of the total pay in 2019.
Evans also received $367.8K in non-equity incentive plan, $472.5K in salary and $1K in other compensation.
Rankings
In 2019, John Evans' compensation ranked 5,419th out of 13,971 executives tracked by ExecPay. In other words, Evans earned more than 61.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,419 out of 13,971 | 61st |
Division Manufacturing | 2,023 out of 5,701 | 65th |
Major group Chemicals And Allied Products | 720 out of 2,200 | 67th |
Industry group Drugs | 604 out of 1,886 | 68th |
Industry Biological Products, Except Diagnostic Substances | 141 out of 389 | 64th |
Source: SEC filing on April 23, 2021.
Evans' colleagues
We found two more compensation records of executives who worked with John Evans at Beam Therapeutics in 2019.